ORX:STO
Orexo AB
1,37 SEK
arrow_downward
-1,58%(-0,022) 1D
6-ноя., 17:29:49 GMT+1 · SEK
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ORX...
Open
1,47 SEK
High
1,47 SEK
Low
1,31 SEK
Mkt. cap
48,05 млн
Avg. vol.
320,60 миң
Volume
525,28 миң
P/E ratio
0,06
52-wk high
36,00 SEK
52-wk low
1,30 SEK
EPS
21,73 SEK
Shares outstanding
35,13 млн
No. of employees
55
Open
1,47 SEK
High
1,47 SEK
Low
1,31 SEK
Mkt. cap
48,05 млн
Avg. vol.
320,60 миң
Volume
525,28 миң
P/E ratio
0,06
52-wk high
36,00 SEK
52-wk low
1,30 SEK
EPS
21,73 SEK
Shares outstanding
35,13 млн
No. of employees
55
News stories
From web sources and news partners
BigGo Finance
·
3 саат мурун
Goldman Sachs Panic Index Breaches Extreme 9.5 Threshold; History Shows S&P 500 Averaged 4.6% Gain Over Following Three Months
TradingView
·
2 саат мурун
Dow, S&P 500, Nasdaq Futures Rebound After Sharp AI Selloff Last Week: NVDA, AMD, VIR, SNDK In Focus
24/7 Wall St.
·
8 саат мурун
Bitcoin's Correlation With the S&P 500 Just Hit 0.80. Is Bitcoin Trading Like a Tech Stock Again?
JournalArta
·
2 саат мурун
Tech Stocks Now Cheaper Than S&P 500 for First Time Since 2017
Profile
Orexo is a Swedish pharmaceutical company that develops improved pharmaceuticals based on innovative formulation technologies that meet large medical needs. Through presence its in the US market, drugs and digital therapies are commercialized to treat opioid use disorder and adjacent diseases. Products targeting other therapeutic areas are developed and commercialized worldwide with partners. Wikipedia
About Orexo AB
CEONikolaj Sørensen
Employees55
Founded1995
Headquarters-
SectorHealth Care
IndustryPharmaceutical industry
Websiteorexo.com